Pleno Inc. Announces First Commercial Agreement with Slopes Bio, Inc.

Slopes Bio to Utilize Pleno’s transformative RAPTOR instruments and consumables for processing more than 100,000 samples annually SAN DIEGO -- Pleno Inc., an early-stage biotechnology company developing innovative multi-omic solutions, and Slopes Bio, Inc., an innovative high-complexity accredited laboratory, today announced a comprehensive commercial agreement in biological target detection and personalized health. The agreement marks the [...]

Ganymede Launches Scientific AI Agent Platform to Accelerate Process Development, R&D, and Manufacturing

PALO ALTO, Calif. -- Ganymede, the scientific data cloud, today announced the launch of its Scientific AI Agent Platform — the first secure, deterministic AI agents purpose-built for science, engineering, and hard tech industries. This marks a significant expansion of Ganymede’s platform with a particular focus on process development, introducing a new category of task-oriented [...]

Bio-Techne Announces Exosome Diagnostics Divestiture

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Bio-Techne will retain access to the proprietary exosome-based technology for ongoing kit development in its precision diagnostics growth pillar. "Mdxhealth is the ideal [...]

Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells

BEACHWOOD, Ohio -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of TrailBio® Hematopoietic Progenitor Cells. These progenitor cells are derived from a single, well-characterized iPSC line using Trailhead's proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, providing researchers with a consistent, scalable, [...]

Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion

Investment to Drive Commercial Growth, Advance Single-Cell Tri-omics Capabilities and Clinical Applications Across Cancer Company Adds to Leadership Team, with Matthew H. Cato Joining as CCO SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. [...]

Promega, Aobious Resolve Patent Infringement Lawsuit

Consent Judgment confirms Aobious infringed Promega patents covering luciferase substrate compounds Settlement includes permanent injunction against Aobious and monetary payments to Promega Promega reaffirms commitment to providing high-quality reagents to scientists through authorized distribution channels MADISON, Wis.--Promega Corporation and Aobious Inc. have entered into a settlement agreement to resolve a patent infringement lawsuit related to [...]

ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform. The G-Rex Grant [...]

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS's multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types [...]

Smiths Detection Announces Acquisition of Med Graphix Inc.

EDGEWOOD, Md. -- Smiths Detection today announces its acquisition of New Jersey-based Med Graphix Inc. ("MGI"), enhancing the company’s sustainable service offering by extending the lifecycle of critical components through repair, refurbishment, and reuse. MGI has been a long-standing service partner and third-party depot supplier for Smiths Detection. This deal marks a significant milestone in [...]

Introducting POLLUX: Our Most Versatile XRD detector yet

We’re proud to unveil POLLUX™, the latest addition to our family of laboratory X-ray detectors - and our most versatile one yet. Built on decades of expertise in Hybrid Photon Counting (HPC) technology, POLLUX was specifically developed for laboratory XRD, empowering scientists and instrument developers with fast, accurate, and energy-discriminating X-ray detection. POLLUX™ redefines what [...]

Access IBO on Knowledge Center